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To estimate the frequency of the use of medicines listed in the Screening Tool to Alert Doctors to the 
Right Treatment (START) and Screening Tool of Older Person’s Prescriptions (STOPP) criteria version 
2 among the elderly. A cross-sectional study was conducted on elderly who were attended in medical 
clinic and cardiology sectors in a hospital in southern Brazil attended at a hospital from February 
through September 2016. A data-collection tool was used to obtain information on variables, such as 
demographic and clinical data, and medications used before and during the hospitalization period. The 
adequacy of the medicines taken was examined with regard to omission (START) or inappropriate use 
(STOPP). This study was approved by the Research Ethics Committee of the University of Southern 
Santa Catarina. A total of 307 subjects were included in the final sample. The mean age was 75.2 years 
(SD = 8; range 65-102). Of the total, 93.5% had had at least one potential prescribing omission (PPO) 
listed in the START criteria, whereas 95.4% used at least one medicine of the STOPP criteria. PPO was 
significantly associated with lower mean age (74.9 years, SD = 7.9 versus 79.0 years, SD = 8.8) among 
the elderly who did not have PPOs detected by the START criteria (p-value=0.03). Furthermore, PPO 
was associated with longer hospital stay (18 versus 9 days; p-value=0.03). This study revealed inadequate 
prescription affecting 99.3% of the participating patients. To the best of our knowledge, this was the first 
to use the START and STOPP criteria, version 2, in Brazil.
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INTRODUCTION 
In recent years, there has been a significant increase 
in the elderly population in all countries, which is attributed 
to the epidemiological transition phenomenon (Kanasi, 
Ayilavarapu, Jones, 2000; WHO, 2015). Longevity brings 
with it chronic disease and increased health resource 
utilization. The most commonly used health intervention 
for the elderly population is the administration of 
medicines (Menesier, Menicier-Ossia, 2017). However, 
polypharmacy can lead to the irrational use of medicines 
(Sivagnanam, 2016). Pharmacological treatments should 
be used with special caution among the elderly people, 
given that their organism presents physiological changes, 
such as decreased muscle mass and body water, as well as 
changes in the absorption, distribution, metabolism, and 
excretion of the medicines. Therefore, pharmacotherapy 
should be differentiated for the elderly, with caution in the 
prescription of medicines (Sánches-Fidalgo et al., 2017; 
Caughey et al., 2017).
Given the potentially serious consequences resulting 
from inadequate prescriptions (Prybys, Gee, 2002), some 
tools have been created for the use of medicines in the 
elderly. These include the Screening Tool to Alert doctors 
to the Right Treatment (START) and Screening Tool 
of Older Persons’ potential inappropriate Prescriptions 
(STOPP). Both were published in 2008 by a panel of 18 
experts in geriatric pharmacology in Ireland and the United iD
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Kingdom (Barry el al., 2007; Gallagher, O’Mahony, 
2008).
The START/STOPP criteria are based on the 
list of potentially prescribing omission (PPO) and 
potentially inappropriate medicines (PIM) in clinical 
practice, respectively Barry el al. (2007) and Gallagher 
and O’Mahony (2008). In 2015, the second version 
expanded to 114 criteria: 34 START criteria and 80 STOPP 
criteria (O’Mahony et al., 2015). The criteria take into 
account pharmacological interactions, contraindications, 
precautions, and therapeutic duplications. This European 
instrument aims to rationalize the use of medicines. It 
acts in the prevention of adverse reactions, reducing 
unnecessary hospital admissions and, as a consequence, 
decreases public health expenditures (O’Mahony et al., 
2015; Hill-Taylor et al., 2013).
The use of inappropriate medicines among elderly 
causes important health impact and assistance to this 
population. The results could highlight the need to develop 
and implement national strategies to identify inadequate 
prescriptions by creating and validating a Brazilian list.
The aim of this study was to estimate the use 
prescription frequency of medicines listed in the START/
STOPP criteria version 2 for hospitalized elderly. 
METHOD
A cross-sectional epidemiological study was 
conducted on the medicines used by elderly patients 
assisted by the Brazilian Unified Health System (SUS), 
who were hospitalized in the medical clinic and cardiology 
sectors in a general hospital, located in southern Brazil. The 
survey was performed from February through September 
2016. The sample size estimation took into account the 
total number of elderly patients hospitalized in the year 
2015, resulting in an estimate of 1,024 hospitalizations. 
A 50% unknown prevalence for the outcome and a 5% 
margin of error were used, resulting in a minimum sample 
of 280 patients for a 95% confidence level.
The sample was selected from the total number of 
hospitalizations during the survey period, and performed 
weekly by using the Tasy® system, a software designed for 
the electronic recording of medical records. Sampling by 
demand was engaged to recruit hospitalized elderly people 
65 years of age and over. Those unable to answer the 
questions because of their clinical condition or discharged 
before the interview were excluded from the study. 
At the first of second day of hospitalization, the 
patients were invited to participate in the study. Those 
who agreed, were asked to sign a free consent form. 
Then, they were interviewed by a trained researcher to 
collect sociodemographic and clinical data, and respond 
to questions about the medications they had taken at home 
the week before. At the end of the hospitalization period, 
the electronic medical records were reviewed to examine 
the prescriptions during the hospital stay and accounts of 
whether they were discharged or died. 
The data-collection tool was designed to obtain 
information on targeted variables, such as gender, age, 
education, comorbidities, reasons for hospitalization, 
vaccination against Influenza and pneumococcus, 
continuous-use medicines and medication administered 
during hospitalization, listed by their generic names, 
classified according to the Anatomical Therapeutic 
Chemical (ATC) (WHO, 2016). The continuous-use 
medicines taken at home was checked through the 
presentation of packages, prescriptions, or reported by the 
patient or companion. 
The START/STOPP criteria version 2 were employed 
to assess medication use in the target population (O’Mahony 
et al., 2015). The START tool is based on 34 criteria that 
indicate the use of certain medicines classes, based on the 
diagnosis and clinical status of elderly persons. The STOPP 
tool is composed of 80 criteria of medicines that should 
not be prescribed or taken by the elderly, except in special 
situations, at the physician discretion. 
Based on the variables obtained, the adequacy of the 
medicines taken at home and at the hospital was examined 
with regard to omission (START) or inappropriate use 
(STOPP). In this study, 22 of the 34 START criteria and 
16 of the 80 STOPP criteria were used. The fact that not all 
criteria were employed in the analysis was due to the lack 
of information related to complementary tests, medicines, 
and diseases that were not reported by the patients.
The collected data were entered into the Microsoft 
Excel 2010 Sheet and analyzed using the SPSS statistical 
package, version 20.0 (IBM, Armonk, New York, USA). 
To verify the association between START/STOPP 
criteria and variables of interest (such as mean age, 
time of hospitalization, number of medicines used and 
comorbidities) the chi-square test was applied, and the 
Student’s t-test was used for mean comparison. When 
the Kolmogorov-Smirnov test revealed non-normal 
distribution, the Wilcoxon Mann-Whitney U test was 
applied. The statistical significance level was set at 0.05.
This study was approved by the Research Ethics 
Committee of the University of Southern Santa Catarina 
(Opinion No 1.207.706).
RESULTS 
A total of 337 elderly persons were recruited for this 
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study. Of these, 30 (8.9%) patients were excluded due to 
hospital discharge before the interview, which resulted in 
a final sample of 307 subjects. Mean age was 75.2 (SD = 8 
years), ranging from 65 to 102 years. The total number of 
medications taken at home by the participants was 1,832, 
mean 6 medicines per patient. During the hospital stay, 
4,617 medicines were prescribed, mean 15 medicines per 
elderly patient.
Table I presents the characteristics of the surveyed 
elderly. 
Mean length of hospital stay was 17.5 days 
(SD = 19.9), with a median of 11 days. Cardiovascular and 
respiratory disorders were the major reasons for admission 
to the hospital. Of the participants, 64 (20.8%) died during 
the hospital stay. 
Table II shows the distribution of the medicines 
taken at home (n = 1,832) and hospital (n = 4,617), 
according to the ATC classification.
The most common classes of medicines taken by 
the elderly before and after hospital admission were 
those of groups C, A, and N, related to the cardiovascular, 
digestive-metabolic and nervous systems, accounting for 
67.0% of all administered medications.
Of the 307 surveyed elderly, 99.3% were affected by 
potentially inappropriate prescribing, of whom 93.5% had 
at least one medicine omission in the START criterion, and 
95.4% had used at least one STOPP medicine. With regard 
to START, 85.0% of the medicines were omitted in the 
home treatment and 90.6% during the hospital stay. With 
regard to STOPP medicines, 54.4% were taken at home, 
and 94.1% were administered in the hospital. The mean 
number of potentially inappropriate medicines per patient 
was 1.6 (SD = 0.7) of the medications used at home, 
ranging from 1 to 4, and 2.8 (SD = 1.5) of the medicines 
administered in the hospital, ranging from 1 to 8.
Of the 344 different types of medicines taken by 
the surveyed elderly, 43 were potentially inappropriate 
medicines, and 27 were from the list of omitted medicines. 
The remaining 274 medicines were not classified by the 
START/STOPP criteria, either because they did not belong 
in this classification, or because of the lack of information 
that could allow a full evaluation.
Table III presents the five most commonly omitted 
medicines in the clinical practice at home (n = 642) and at 
the hospital (n = 582) by the surveyed elderly, according 
to the START criterion.
Regarding the PPOs according to the START 
criterion, patients with a lower mean age (74.9, SD = 7.9 
years) had a larger number of medicines omissions as 
compared to patients with a higher mean age (79.0, SD = 
8.8 years), (p = 0.03). Furthermore, prescribing omissions 
were associated with a longer hospital stay, (18 days versus 
9 days), (p = 0.03).
The START criteria also showed a statistically 
significant association with coronary, cerebral or 
peripheral vascular disease (p = 0.039), depression (p = 
0.004), diabetes mellitus (p <0.001), chronic obstructive 
pulmonary disease (p = 0,047), and systemic arterial 
hypertension (p <0.001).
Regarding immunoprophylaxis, 26.1% of the 
patients reported that they had not taken the vaccine 
against Influenza, and 89.9% against pneumococcus. 
These vaccines are indicated for elderly patients and are 
listed in the START criterion.
TABLE I - Characteristics of the surveyed elderly hospitalized, 
from February through September 2016. Tubarão (SC), Brazil. 
(n = 307)
Characteristics n (%)
Age (years)
65-69 98 (31.9)
70-74 62 (20.2)
75-79 61 (19.9)
≥ 80 86 (28.0)
Gender
Male 134 (43.6)
Female 173 (56.4)
Education
Illiterate 34 (11.1)
Primary school 253 (82.4)
Secondary school 18 (5.9)
College degree 2 (0.6)
Time of hospitalization (days)
1-3 22 (7.2)
4-7 65 (21.2)
8-15 109 (35.5)
>15 111 (36.1)
Comorbities* (n=1,509)
Respiratory disease 104 (6.9)
Cardiovascular disease 488 (32.3)
Gastrointestinal disorders 200 (13.3)
Metabolic disease 254 (16.8)
Nervous system disease 140 (9.3)
Muscoloskeletal disease 170 (11.3)
Other 153 (10.1)
*some patients had more than one comorbities.
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Table IV presents the frequency of the five potentially 
inappropriate medicines most commonly taken at home 
(n = 318) and at the hospital (n = 799), according to the 
STOPP criterion.
Omeprazole, clonazepam, and furosemide were the 
most commonly used medicines at home, accounting for 
12.3% of those considered potentially inappropriate. At 
the hospital, the most commonly used medicines were 
omeprazole, furosemide, and tramadol, accounting for 
25.0% of those considered potentially inappropriate. 
TABLE II - Distribution of the medicines taken by the surveyed elderly hospitalized, from February through September 2016, 
according to the ATC classification. Tubarão (SC), Brazil
Code Contents
Prescription frequency  
n (%)
Home Hospital
A Alimentary tract and metabolism 355 (19.3) 950 (20.6)
B Blood and blood forming organs 235 (12.8) 530 (11.5)
C Cardiovascular system 767 (41.9) 1,120 (24.2)
D Dermatologicals 7 (0.4) 193 (4.2)
G Genitourinary system and sex hormones 5 (0.3) 18 (0.4)
H Systemic hormonal preparations, excluding sex hormones and insulins 3 (0.2) 102 (2.2)
J Antiinfectives for systemic use 22 (1.2) 377 (8.2)
L Antineoplastic and immunomodulating agents 8 (0.4) 10 (0.2)
M Musculoskeletal system 28 (1.5) 46 (1.0)
N Nervous system 312 (17.0) 814 (17.6)
P Antiparasitic products, insecticides and repellents 0 (0.0) 9 (0.2)
R Respiratory system 84 (4.6) 425 (9.2)
S Sensory organs 3 (0.2) 20 (0.4)
V Various 3 (0.2) 3 (0.1)
Total 1,832 (100.0) 4,617 (100.0)
TABLE III - Frequency of the five most commonly omitted medicines either at home or at the hospital by the surveyed elderly from 
February through September 2016, of those considered potentially appropriate according to the START criterion. Tubarão (SC), 
Brazil
Major potentially appropriate medicines omitted from the clinical practice, according to the START criteria n (%)
At home (n=642)
Antihypertensive therapy – if there was a history of systemic arterial hypertension 237 (36.9)
β2 agonist or inhaled corticosteroid – if there was a chronic obstructive pulmonary disease or asthma 112 (17.4)
Statins – if there was a history of coronary, cerebral or peripheral vascular disease 63 (9.8)
Tricyclic antidepressants - if there was a history of depression 46 (7.2)
Bisphosphonates, vitamin D or calcium – if there was osteoporosis 34 (5.3)
At the hospital (n=582)
Antihypertensive therapy – if there was a history of systemic arterial hypertension 244 (41.9)
Laxatives - in patients receiving opioids regularly 95 (16.3)
Statins – if there was a history of coronary, cerebral or peripheral vascular disease 49 (8.4)
Tricyclic antidepressant - if there was a history of depression 43 (7.4)
Bisphosphonates, vitamin D or calcium – if there was osteoporosis 33 (5.7)
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DISCUSSION
Medicines are considered potentially inappropriate 
for the elderly when there is no evidence-based clinical 
indication, and when they increase the risk of adverse 
effects or are not cost-effective (O’Mahony, Gallagher, 
2008). Most study participants had at least one inadequate 
medicine prescription detected by the START/STOPP 
criteria. These findings are in line with other published 
works (Mori et al., 2017; Gallagher et al., 2011).
According to Pérez and colleagues, the definition of 
polypharmacy is controversial because it can mean the use 
of one medicine to correct the adverse effect of another, 
or taking five or more medicines simultaneously (Peréz et 
al., 2016). This study identified that the surveyed elderly 
took a large number of medicines (more than 5 per person), 
either before or after hospital admission, which confirmed 
the findings of other published works (Gutiérrez-Valencia 
et al., 2017; Ubeda et al., 2012).
With regard to the START criteria, antihypertensive 
medicines were the most commonly omitted prescribed 
PIMs, both at home and at the hospital, which means 
that antihypertensive therapy was not applied correctly, 
leading to therapeutic omission. In contrast to these results, 
other studies revealed that the most frequent therapeutic 
omissions occurred with statins, generally in patients 
with a history of coronary, cerebral or peripheral vascular 
disease (Anthierens et al., 2010; Olaniyan et al., 2015). 
Despite the different findings, in both cases, there was 
an underutilization of medicines, which may worsen the 
symptoms, disease control, and health status of the elderly 
(Anthierens et al., 2010). Furthermore, it may result in the 
need for additional prescription of larger doses or more 
potent therapies, which, in turn, may increase the risk of 
adverse reactions, as well as other negative outcomes, such 
as an increased number of visits to emergency services, 
hospitalizations, and deaths (Koper et al., 2013). 
In this study, medicines omissions were associated 
with a lower mean age. Elderly patients with a lower 
age range may be more independent than those with a 
higher age range, which would explain the occurrence of 
medicine omission. In more advanced age groups, patients 
tend to need more medical care, which may explain a 
reduction in medicine omission. However, the risk of 
taking PIMs increases in the elderly (Marroquín et al., 
2012). This scenario may result in an iatrogenic cascade, 
which occurs when the adverse effect of a medicine is 
misinterpreted as a new condition requiring repeated 
prescription, exposing the patient to possible additional 
detrimental effects related to pharmacological treatment 
(Garcia-Gollarte et al., 2012). These medication-related 
problems affect especially older people.
Patients who had a larger number of medicine 
omissions detected by the START criteria remained 
hospitalized twice as long as their counterparts. 
During hospitalization, patients are often treated by 
multiple physicians. As a consequence, their medicines 
prescriptions are vulnerable to iatrogenic effects, given 
TABLE IV - Frequency of the five most commonly prescribed medications taken at home and at the hospital by the surveyed elderly, 
from February through September 2016, considered potentially inappropriate, according to the STOPP criterion, 2016. Tubarão 
(SC), Brazil
Major potentially inappropriate drugs prescribed according to STOPP criteria n (%)
At home (n = 318)
Omeprazole – If there was no history of gastroesophageal reflux disease, peptic ulcer, or gastritis 58 (18.2) 
Clonazepam - Benzodiazepines can impair balance 43 (13.5) 
Furosemide – If it was first line for systemic arterial hypertension 37 (11.6)
Spironolactone - Associated with angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, or 
amiloride
32 (10.1)
Glibenclamide - May cause hypoglycemia if taken for a long time 22 (6.9)
At the hospital (n=799)
Omeprazole – If there was no history of gastroesophageal reflux disease, peptic ulcer, or gastritis 129 (16.1)
Furosemide – If it was first line for systemic arterial hypertension 81 (10.1)
Tramal - Opioids without laxatives can cause chronic constipation 70 (8.8)
Clonazepam - Benzodiazepines can impair balance 62 (7.8)
Spironolactone - Associated with angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, or 
amiloride
50 (6.3)
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that treatment is complex and involves a sequence of 
steps, such as prescription, communication, dispensing, 
administration, and clinical follow-up, which require more 
attention, especially in elderly patients (Saint-Germain et 
al., 2016).
With regard to the PPOs detected by the START 
criteria, there was a statistically significant association with 
coronary, cerebral, and peripheral vascular disease. It is 
well known that the leading causes of hospital admissions 
and deaths among the elderly are cardiovascular diseases, 
as previously mentioned. This study revealed that this 
comorbidity was neglected, given that the clinical 
situation required the prescription of medications, which 
was omitted. Furthermore, diabetes mellitus, depression, 
chronic obstructive pulmonary disease, and systemic 
arterial hypertension were also associated with prescribing 
omission. Such diseases, when not treated properly, may 
cause unfavorable fatal and nonfatal outcomes (Navar, 
Pencina, Peterson, 2016).
Influenza and pneumonia are the major causes 
of morbidity and mortality in patients with chronic 
obstructive pulmonary disease. Influenza vaccination 
reduces acute exacerbations, and the pneumococcal 
vaccine reduces the incidence of pneumonia (Di Giorgio, 
Provenzani, Polidori, 2016). Most of the participants in 
this study did not receive the anti-pneumococcal vaccine 
(89.9%) and stated that they were not aware of this type of 
immunization. Moreover, 26.1% did not get a vaccination 
against Influenza. Both vaccines are recommended by the 
START criterion, and they should not be omitted. These 
data indicate the need for improvements in immunization 
campaigns, especially targeted at the elderly, as a strategy 
designed to increase prophylaxis adherence. 
It should be noted that the use of medications was 
higher during hospitalization than at home. This fact 
can be explained by the fact that patients are admitted 
to the hospital in acute situations or when there are 
morbid complications derived from the aging process. 
Management of each case culminates in the prescription of 
more drugs to treat and control these clinical situations, in 
addition to continuous-use medications that must continue 
during the hospitalization period. These circumstances 
may increase the chances of using potentially inappropriate 
drugs or omission of others, in the absence of a medication 
reconciliation process. In fact, in the present study, the 
omission or inappropriate use of medications occurred 
more frequently in the hospital setting than at home.
With regard to the STOPP criterion, a comparison 
between medications taken at home and those taken 
at the hospital revealed that the prescription of PIMs 
increased during hospitalization. This distortion may 
be associated with the lack of regular review of the 
therapeutic regimen by health professionals. Strict 
compliance with clinical protocols should be the standard, 
otherwise the prescription of numerous medications may 
occur (Filkelstein et al., 2016b). In this context, it is 
worth mentioning that some studies have demonstrated 
that polypharmacy may increase the risk of PIM use 
(Sánchez-Fidalgo et al., 2017; Filkelstein et al., 2016a; 
Nascimento et al., 2014). A study conducted by Melo 
and colleagues (Melo, Storpirtis, Ribeiro, 2016) found 
that a medication therapy review by a clinical pharmacist 
resulted in a reduction in polypharmacy and PIMs after 
the hospitalization period. 
With regard to the STOPP criteria, there was no 
statistically significant association between the use of PIM 
and the other variables collected. Because most patients 
took at least one PIM medication, and because the sample 
was homogeneous in relation to the outcome, the statistical 
analysis was compromised and could not show differences 
between the groups.
The most common PIMs taken at home or at the 
hospital, as detected by the STOPP criteria, belonged to 
the class of proton pump inhibitors, especially omeprazole. 
According to the STOPP criteria, this class of medicines 
should not be prescribed for patients who do not have a 
history of gastroesophageal reflux disease, peptic ulcer, or 
gastritis. These findings are consistent with those found in 
other studies (Cahir et al., 2010).
The findings from this study strengthen the need 
to create a national criterion on medication to be 
used by the elderly population, which would include 
potentially inappropriate medicines and those that 
should be prescribed specifically for this age group. 
This criterion would depict the Brazilian reality based 
on the list of essential medicines, whilst it will also 
provide guidance on rational prescription to healthcare 
professionals. The presence of clinical pharmacists both 
at the outpatient clinic and in the hospital setting is vital 
to help prescribers on the rational use of drugs, especially 
for the elderly population. A search software system 
and a list of potentially inappropriate medications are 
useful tools for prescribers and dispensers. It should be 
emphasized that the criteria applied will not prohibit the 
use of medicines, given that prescriptions will always 
depend on the situation and clinical decision, in addition 
to the individual characteristics of each patient (Lozano-
Montoya et al., 2015). This study neither evaluated the 
individual clinical history nor discussed the therapeutic 
choice with the attending physician. In addition, the results 
cannot be generalized since the study was conducted in a 
single center.
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It should be noted that not all START and STOPP 
criteria could be used in this study, because of the lack 
of clinical data and complementary tests, which was a 
limitation to the study. It should also be noted that there 
was a difference between the medications used at home, 
which were prescribed at an outpatient clinic, and those 
used in a hospital setting, with more complex clinical 
situations and less time available by the medical team to 
assess the safety of prescribed drugs, because of urgency 
in the acute situations.
In closing, this study was based on a representative 
sample and was the first to use the START and STOPP 
criteria, version 2, in Brazil to analyze medicines 
prescriptions before and after hospital admission. Further 
longitudinal studies should be conducted to investigate 
the risk factors associated with PIM and PPO and their 
consequences in order to provide a rational use of 
medicines among the elderly people.
CONCLUSION
The results from this study showed that potentially 
inappropriate prescribing affected 99.3% of the surveyed 
patients. Of the total prescriptions, 95.4% were related to 
inappropriate medicines, which could be suspended or 
modified according to the STOPP criterion, and 93.5% 
were prescribing omissions of appropriate medicines, as 
detected by the START criterion. This study highlights 
the need to develop and implement national strategies 
to identify inadequate prescriptions by creating and 
validating a Brazilian list of medicines for the elderly 
people. Such a list should be widely disseminated to 
all health facilities to guide decisions about rational 
prescription and therapeutic use of medicines for the 
elderly population. 
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